Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0460 Transporter Info
Gene Name	SLC6A8
Transporter Name	Creatine transporter 1
Gene ID	6535
UniProt ID	P48029

Post-Translational Modification of This DT
Overview of SLC6A8 Modification Sites with Functional and Structural Information
Sequence	M A K K S A E N G I Y S V S G D E K K G P L I A P G P D G A P A K G D G P V G L G T P G G R L A V P P R E T W T R Q M D F I M S C V G F A V G L G N V W R F P Y L C Y K N G G G V F L I P Y V L I A L V G G I P I F F L E I S L G Q F M K A G S I N V W N I C P L F K G L G Y A S M V I V F Y C N T Y Y I M V L A W G F Y Y L V K S F T T T L P W A T C G H T W N T P D C V E I F R H E D C A N A S L A N L T C D Q L A D R R S P V I E F W E N K V L R L S G G L E V P G A L N W E V T L C L L A C W V L V Y F C V W K G V K S T G K I V Y F T A T F P Y V V L V V L L V R G V L L P G A L D G I I Y Y L K P D W S K L G S P Q V W I D A G T Q I F F S Y A I G L G A L T A L G S Y N R F N N N C Y K D A I I L A L I N S G T S F F A G F V V F S I L G F M A A E Q G V H I S K V A E S G P G L A F I A Y P R A V T L M P V A P L W A A L F F F M L L L L G L D S Q F V G V E G F I T G L L D L L P A S Y Y F R F Q R E I S V A L C C A L C F V I D L S M V T D G G M Y V F Q L F D Y Y S A S G T T L L W Q A F W E C V V V A W V Y G A D R F M D D I A C M I G Y R P C P W M K W C W S F F T P L V C M G I F I F N V V Y Y E P L V Y N N T Y V Y P W W G E A M G W A F A L S S M L C V P L H L L G C L L R A K G T M A E R W Q H L T Q P I W G L H H L E Y R A Q D A D V R G L T T L T P V S E S S K V V V V E S V M
PTM type	X-Acetylation X-Methylation X-N-glycosylation X-O-glycosylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

Acetylation
Lysine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC6A8			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	18
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC6A8 Lysine 18 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC6A8			[2]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	19
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC6A8 Lysine 19 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC6A8			[3]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	33
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC6A8 Lysine 33 has the potential to affect its expression or activity.
Methylation
Arginine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC6A8			[4]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	614
Experimental Method	Co-Immunoprecipitation
Detailed Description	Methylation at SLC6A8 Arginine 614 has the potential to affect its expression or activity.
N-glycosylation
Asparagine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC6A8			[4]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	192
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC6A8 Asparagine 192 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC6A8			[4]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	197
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC6A8 Asparagine 197 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC6A8			[4]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	548
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC6A8 Asparagine 548 has the potential to affect its expression or activity.
O-glycosylation
Serine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC6A8			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	623
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC6A8 Serine 623 has the potential to affect its expression or activity.
Oxidation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC6A8			[6]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	82
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC6A8 Cystine 82 has the potential to affect its expression or activity.
Phosphorylation
Serine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC6A8			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	5
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A8 Serine 5 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC6A8			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	12
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A8 Serine 12 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC6A8			[7] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	14
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A8 Serine 14 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC6A8			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	361
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A8 Serine 361 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC6A8			[11] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	623
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A8 Serine 623 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC6A8			[11] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	625
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A8 Serine 625 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC6A8			[11] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	626
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A8 Serine 626 has the potential to affect its expression or activity.
Threonine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC6A8			[13] , [14]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	42
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A8 Threonine 42 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC6A8			[13]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	54
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A8 Threonine 54 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC6A8			[13]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	56
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A8 Threonine 56 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC6A8			[12] , [14]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	617
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A8 Threonine 617 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC6A8			[11] , [12]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	618
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A8 Threonine 618 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC6A8			[12] , [14]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	620
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A8 Threonine 620 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC6A8			[7] , [15]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	11
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A8 Tyrosine 11 has the potential to affect its expression or activity.
Ubiquitination
Lysine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC6A8			[16]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	4
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC6A8 Lysine 4 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC6A8			[16]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	18
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC6A8 Lysine 18 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC6A8			[17]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	19
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC6A8 Lysine 19 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC6A8			[16]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	33
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC6A8 Lysine 33 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC6A8			[16]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	217
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC6A8 Lysine 217 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC6A8			[18]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	627
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC6A8 Lysine 627 has the potential to affect its expression or activity.

References
1	Inefficacy of oral antidiabetics: failure or natural history of diabetes? Rev Med Suisse Romande. 1995 Sep;115(9):671-3.
2	Pattern of somatic androgen receptor gene mutations in patients with hormone-refractory prostate cancer. Lab Invest. 2002 Nov;82(11):1591-8.
3	Dynamics of the alpha6beta4 integrin in keratinocytes. Mol Biol Cell. 2002 Nov;13(11):3845-58.
4	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: SC6A8_HUMAN)
5	Quantitative proteomics identifies altered O-GlcNAcylation of structural, synaptic and memory-associated proteins in Alzheimer's disease. J Pathol. 2017 Sep;243(1):78-88.
6	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
7	Phosphotyrosine-based-phosphoproteomics scaled-down to biopsy level for analysis of individual tumor biology and treatment selection. J Proteomics. 2017 Jun 6;162:99-107.
8	Phosphotyrosine profiling of curcumin-induced signaling. Clin Proteomics. 2016 Jun 15;13:13.
9	Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways. Oncotarget. 2015 Oct 6;6(30):29143-60.
10	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
11	Comparative phosphoproteomic analysis reveals signaling networks regulating monopolar and bipolar cytokinesis. Sci Rep. 2018 Feb 2;8(1):2269.
12	Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
13	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
14	UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
15	Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder. Nat Chem Biol. 2016 Nov;12(11):959-966.
16	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.
17	Processing fate of protein antigen attached to IgD or MHC molecules on normal B lymphocytes using heterocrosslinked bispecific antibodies. Mol Immunol. 1991 Jul;28(7):779-88.
18	New findings on essential amino acids. Cesk Fysiol. 1990;39(1):13-25.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence